Literature DB >> 31178263

Corrigendum to "Luteolin, a flavonoid, as an anticancer agent: A review" [Biomed. Pharmacother. 112 (2019) 108612].

Muhammad Imran1, Abdur Rauf2, Tareq Abu-Izneid3, Muhammad Nadeem4, Mohammad Ali Shariati5, Imtiaz Ali Khan6, Ali Imran7, Ilkay Erdogan Orhan8, Muhammad Rizwan9, Muhammad Atif10, Tanweer Aslam Gondal11, Mohammad S Mubarak12.   

Abstract

Entities:  

Year:  2019        PMID： 31178263     DOI： 10.1016/j.biopha.2019.109084

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN： 0753-3322            Impact factor:   6.529


× No keyword cloud information.
  4 in total

1.  Luteolin attenuates angiotensin II‑induced renal damage in apolipoprotein E‑deficient mice.

Authors:  Ying-Shu Liu; Qin Yang; Shen Li; Lan Luo; Hong-Yang Liu; Xin-Yu Li; Zheng-Nan Gao
Journal:  Mol Med Rep       Date:  2020-12-23       Impact factor: 2.952

2.  Towards Splicing Therapy for Lysosomal Storage Disorders: Methylxanthines and Luteolin Ameliorate Splicing Defects in Aspartylglucosaminuria and Classic Late Infantile Neuronal Ceroid Lipofuscinosis.

Authors:  Antje Banning; Ritva Tikkanen
Journal:  Cells       Date:  2021-10-20       Impact factor: 7.666

3.  Potential active compounds and molecular mechanism of Xuefu Zhuyu decoction for atherosclerosis, based on network pharmacology and molecular docking.

Authors:  Yingyun Li; Boyu Liu; Lin Liu; Qing Xu; Quan Shen; Weikang Li; Jingshan Zhao
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

4.  The Olive Leaves Extract Has Anti-Tumor Effects against Neuroblastoma through Inhibition of Cell Proliferation and Induction of Apoptosis.

Authors:  Fabio Morandi; Veronica Bensa; Enzo Calarco; Fabio Pastorino; Patrizia Perri; Maria Valeria Corrias; Mirco Ponzoni; Chiara Brignole
Journal:  Nutrients       Date:  2021-06-24       Impact factor: 5.717
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.